Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer

Open access

Abstract

Aberrant expression of the pluripotency-associated transcription factor Sox2 is associated with poor prognosis in colorectal cancer (CRC). We investigated the regulatory roles of major post-translational modifications in Sox2 using two CRC cell lines, SW480 and SW620, derived from the same patient but with low and high Sox2 expression, respectively. Acetylation of K75 in the Sox2 nuclear export signal was relatively increased in SW480 cells and promotes Sox2 nucleocytoplasmic shuttling and proteasomal degradation of Sox2. LC-MS-based proteomics analysis identified HDAC4 and p300 as binding partners involved in the acetylation-mediated control of Sox2 expression in the nucleus. Sox2 K75 acetylation is mediated by the acetyltransferase activity of CBP/p300 and ACSS3. In SW620 cells, HDAC4 deacetylates K75 and is regulated by miR29a. O-GlcNAcylation on S246, in addition to K75 acetylation, also regulates Sox2 stability. These findings provide insights into the regulation of Sox2 through multiple post-translational modifications and pathways in CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers16051035

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Difference of Sox2 expression and lysine acetylation between SW480 cells and SW620 cells. (A) Immunofluorescence staining of SW480 and SW620 cells with anti-Sox2 antibody (green) reveals differential expression of endogenous Sox2 between the two cell lines. Scale bar, 10 μm. (B) Nuclear and cytosolic fractions were obtained by fractionation followed by Western blot analysis to examine the amount and localization of Sox2 in SW480 and SW620 cells. HDAC1 and α-tubulin were used as loading and fractionation controls for the nuclear and cytosolic fractions, respectively. Data represent three independent experiments. Bar graphs depict the means ± SEM. Statistical significance was determined using unpaired Student’s t-tests (** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7. (C) Immunoprecipitation using anti-Sox2 and immunoblotting using Ace-K antibody were performed after SW480 and SW620 cells were treated with MG132 (25 nM) for 24 h. Full-length blots/gels are presented in Supplementary Figure S7.
Figure 1 Difference of Sox2 expression and lysine acetylation between SW480 cells and SW620 cells. (A) Immunofluorescence staining of SW480 and SW620 cells with anti-Sox2 antibody (green) reveals differential expression of endogenous Sox2 between the two cell lines. Scale bar, 10 μm. (B) Nuclear and cytosolic fractions were obtained by fractionation followed by Western blot analysis to examine the amount and localization of Sox2 in SW480 and SW620 cells. HDAC1 and α-tubulin were used as loading and fractionation controls for the nuclear and cytosolic fractions, respectively. Data represent three independent experiments. Bar graphs depict the means ± SEM. Statistical significance was determined using unpaired Student’s t-tests (** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7. (C) Immunoprecipitation using anti-Sox2 and immunoblotting using Ace-K antibody were performed after SW480 and SW620 cells were treated with MG132 (25 nM) for 24 h. Full-length blots/gels are presented in Supplementary Figure S7.CC BY · PubMed Central
Figure 2 Difference in K75 acetylation between SW480 cells and SW620 cells. (A) Acetylation of the K75 residue in SW480 and SW620 cells was verified by manual inspection of LC-MS/MS spectra. Endogenous Sox2 proteins from SW480 and SW620 cells were fractionated with trypsin, and the difference in K75 acetylation within the ‘MHNSEISKRLGAE’ sequence was confirmed. Details of the mass spectrometric analysis and database search can be found in the Materials and Methods section. (B) SW480 cells were transfected with plasmids encoding Myc-Sox2 wild-type and K75Q and K75R mutants. After 48 h, the transfected cells were subjected to immunoprecipitation using an anti-Myc antibody. Western blot was subsequently performed using anti-Ace-K, Myc, and a-tubulin antibodies. Full-length blots/gels are presented in Supplementary Figure S7. (C) The subcellular localization of Sox2 was determined in nuclear (NE) and cytosolic (CE) fractions of SW480 cells transfected with Myc-Sox2 wild-type and K75Q and K75R mutants. HDAC1 and α-tubulin were used as loading and fractionation controls. Full-length blots/gels are presented in Supplementary Figure S7. (D) SW480 cells were transfected with Myc-Sox2 wild-type and K75Q and K75R mutants for 48 h and then fixed and stained with anti-Myc (green). DAPI was used to indicate the nuclei. Scale bar, 10 μm.
Figure 2 Difference in K75 acetylation between SW480 cells and SW620 cells. (A) Acetylation of the K75 residue in SW480 and SW620 cells was verified by manual inspection of LC-MS/MS spectra. Endogenous Sox2 proteins from SW480 and SW620 cells were fractionated with trypsin, and the difference in K75 acetylation within the ‘MHNSEISKRLGAE’ sequence was confirmed. Details of the mass spectrometric analysis and database search can be found in the Materials and Methods section. (B) SW480 cells were transfected with plasmids encoding Myc-Sox2 wild-type and K75Q and K75R mutants. After 48 h, the transfected cells were subjected to immunoprecipitation using an anti-Myc antibody. Western blot was subsequently performed using anti-Ace-K, Myc, and a-tubulin antibodies. Full-length blots/gels are presented in Supplementary Figure S7. (C) The subcellular localization of Sox2 was determined in nuclear (NE) and cytosolic (CE) fractions of SW480 cells transfected with Myc-Sox2 wild-type and K75Q and K75R mutants. HDAC1 and α-tubulin were used as loading and fractionation controls. Full-length blots/gels are presented in Supplementary Figure S7. (D) SW480 cells were transfected with Myc-Sox2 wild-type and K75Q and K75R mutants for 48 h and then fixed and stained with anti-Myc (green). DAPI was used to indicate the nuclei. Scale bar, 10 μm.CC BY · PubMed Central
Figure 3 P300-induced lysine acetylation of Sox2 induces nuclear export of Sox2. (A) Immunoprecipitation was performed using anti-p300 antibody on SW480 and SW620 cell lysates, followed by immunoblotting using antibodies against Acetyl-lysine, p300, and vinculin. Full-length blots/gels are presented in Supplementary Figure S7. (B,C) Immunoprecipitation of Sox2 was performed on SW480 cell lysates treated with or without the histone acetyltransferase p300 inhibitor C646 (10 μM) for 24 h. Western blot was performed using antibodies against Acetyl-lysine, Sox2 a-tubulin and Crm1. Full-length blots/gels are presented in Supplementary Figure S7. (D) To assess Sox2 binding to Crm1 under conditions of protection from proteasomal degradation, SW480 cells were treated with MG132 (25 nM) for 24 h. Immunoprecipitation was then performed using anti-Sox2, followed by immunoblotting with an Ace-K antibody and anti-Crm1. Full-length blots/gels are presented in Supplementary Figure S7.
Figure 3 P300-induced lysine acetylation of Sox2 induces nuclear export of Sox2. (A) Immunoprecipitation was performed using anti-p300 antibody on SW480 and SW620 cell lysates, followed by immunoblotting using antibodies against Acetyl-lysine, p300, and vinculin. Full-length blots/gels are presented in Supplementary Figure S7. (B,C) Immunoprecipitation of Sox2 was performed on SW480 cell lysates treated with or without the histone acetyltransferase p300 inhibitor C646 (10 μM) for 24 h. Western blot was performed using antibodies against Acetyl-lysine, Sox2 a-tubulin and Crm1. Full-length blots/gels are presented in Supplementary Figure S7. (D) To assess Sox2 binding to Crm1 under conditions of protection from proteasomal degradation, SW480 cells were treated with MG132 (25 nM) for 24 h. Immunoprecipitation was then performed using anti-Sox2, followed by immunoblotting with an Ace-K antibody and anti-Crm1. Full-length blots/gels are presented in Supplementary Figure S7.CC BY · PubMed Central
Figure 4 Analysis of Sox2 binding partners and the role of ACSS2-mediated p300 activity during Sox2 degradation. (A,B) The experimental design for identifying Sox2 binding partners using Flag-immunoprecipitation coupled with LC-MS/MS. Immunoprecipitation (IP) was performed using anti-Flag antibody-conjugated beads or resin to specifically isolate the Flag-tagged Sox2 protein complexes from cell lysates. LC-MS/MS analysis was then carried out to identify the interacting proteins. The number of peptides binding to Flag was quantified using the MS flag tool (https://www.flag-ms.com/, accessed on 30 January 2024) and presented in (B). (C) A doxycycline-inducible Sox2-overexpressing stable cell line (pCW57-Flag-Sox2) was treated with doxycycline for 48 h and 72 h, followed by pull-down assay using the Flag tag. Then, immunoblotting was performed using a p300 antibody. Mouse IgG was used as a control for the pull-down assay. Full-length blots/gels are presented in Supplementary Figure S7. (D) Subcellular localization of Sox2 was determined in nuclear (NE) and cytosolic (CE) fractions of pCW57-Flag-Sox2 cells treated with doxycycline (1 μg/mL) for 48 h or 72 h or co-treated with doxycycline and the ACSS2 inhibitor VY3-135 (10 μM) for 48 h or 72 h. HDAC1 and α-tubulin were used as loading and fractionation controls. Full-length blots/gels are presented in Supplementary Figure S7. (E) Correlation analysis of ACSS2 expression and Sox2 expression was performed using RNA-seq data of stage Ⅲ CRC tissues (n = 115, R = 0.34, p < 0.0052). (F) SW480 cells were treated with VY3-135 (10 μM) for 24, 48, or 72 h. The mRNA and protein expression levels of Sox2 and HDAC4 were analyzed by qPCR and Western blot, respectively. Presented data represent at least two independent experiments. Statistical significance was determined using unpaired Student's t-tests (*** p < 0.001). Full-length blots/gels are presented in Supplementary Figure S7. (G) Human normal colon organoids were treated with VY3-135 (10 μM) for 24, 48, or 72 h. The mRNA levels of Sox2 and HDAC4 were evaluated relative to RPL3A expression (reference gene) using qPCR, and the protein levels of Sox2 and HDAC4 were assessed by immunoblotting using organoid cell lysates. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, ** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7.
Figure 4 Analysis of Sox2 binding partners and the role of ACSS2-mediated p300 activity during Sox2 degradation. (A,B) The experimental design for identifying Sox2 binding partners using Flag-immunoprecipitation coupled with LC-MS/MS. Immunoprecipitation (IP) was performed using anti-Flag antibody-conjugated beads or resin to specifically isolate the Flag-tagged Sox2 protein complexes from cell lysates. LC-MS/MS analysis was then carried out to identify the interacting proteins. The number of peptides binding to Flag was quantified using the MS flag tool (https://www.flag-ms.com/, accessed on 30 January 2024) and presented in (B). (C) A doxycycline-inducible Sox2-overexpressing stable cell line (pCW57-Flag-Sox2) was treated with doxycycline for 48 h and 72 h, followed by pull-down assay using the Flag tag. Then, immunoblotting was performed using a p300 antibody. Mouse IgG was used as a control for the pull-down assay. Full-length blots/gels are presented in Supplementary Figure S7. (D) Subcellular localization of Sox2 was determined in nuclear (NE) and cytosolic (CE) fractions of pCW57-Flag-Sox2 cells treated with doxycycline (1 μg/mL) for 48 h or 72 h or co-treated with doxycycline and the ACSS2 inhibitor VY3-135 (10 μM) for 48 h or 72 h. HDAC1 and α-tubulin were used as loading and fractionation controls. Full-length blots/gels are presented in Supplementary Figure S7. (E) Correlation analysis of ACSS2 expression and Sox2 expression was performed using RNA-seq data of stage Ⅲ CRC tissues (n = 115, R = 0.34, p < 0.0052). (F) SW480 cells were treated with VY3-135 (10 μM) for 24, 48, or 72 h. The mRNA and protein expression levels of Sox2 and HDAC4 were analyzed by qPCR and Western blot, respectively. Presented data represent at least two independent experiments. Statistical significance was determined using unpaired Student's t-tests (*** p < 0.001). Full-length blots/gels are presented in Supplementary Figure S7. (G) Human normal colon organoids were treated with VY3-135 (10 μM) for 24, 48, or 72 h. The mRNA levels of Sox2 and HDAC4 were evaluated relative to RPL3A expression (reference gene) using qPCR, and the protein levels of Sox2 and HDAC4 were assessed by immunoblotting using organoid cell lysates. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, ** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7.CC BY · PubMed Central
Figure 5 HDAC4 depletion promotes cytoplasmic shift and degradation of Sox2 via increased lysine acetylation. (A) SW620 cells were treated with different concentrations of the deacetylase inhibitor trichostatin A (TSA; 10, 20, or 30 nM) for 48 h. The expression of HDAC4, HDAC1, Sox2, and Vinculin was examined by Western blot and qPCR. Data represent three independent experiments. Bar graphs show means ± SEM. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, ** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7. (B) SW620 cells were treated with 5 nM TSA for 24 h, followed by immunofluorescence staining with anti-Sox2 (green). Scale bar, 10 μm. (C) Immunofluorescence staining was performed using anti-Sox2 (green) and HDAC4 (red) antibodies to visualize their localization in SW480 and SW620 cells. Scale bar, 10 μm. (D) SW480 and SW620 cells were transfected with control or HDAC4 siRNA (20 nM) for 48 h. Cell lysates were analyzed by Western blot using anti-HDAC4, Sox2, and GAPDH antibodies. Full-length blots/gels are presented in Supplementary Figure S7. (E) SW620 cells were transfected with HDAC4 siRNA (20 nM) for 48 h, and the expression of Sox2 (green) was analyzed by immunofluorescence. Scale bar, 10 μm. (F) SW620 cells were transfected with control, HDAC1 or HDAC4 siRNAs (20 nM) for 48 h, with additional MG132 (25 nM) treatment for 24 h. Then, lysates were immunoprecipitated with lysine acetylation antibody, followed by Western blot analysis using anti-Sox2 antibody. Full-length blots/gels are presented in Supplementary Figure S7. (G) After fractionation into nuclear (NE) and cytosol (CE) fractions, SW620 cells were subjected to immunoprecipitation using Sox2 antibody. Western blot was performed with anti-HDAC4 and Sox2 antibodies. HDAC1 and GAPDH were used as loading controls for nuclear and cytosolic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (H) SW480 cells were co-transfected with plasmids encoding Flag-HDAC4 and Myc-Sox2 wild-type, K75Q mutant, or K75R mutant to investigate the interaction between Sox2 and HDAC4. After 48 h, cell lysates were immunoprecipitated with anti-Myc antibody, followed by immunoblot analysis using the indicated antibodies. Full-length blots/gels are presented in Supplementary Figure S7. (I) Kaplan–Meier curves for disease-free survival analysis were generated based on HDAC4-negative (n:135) and -positive (n:30) expression detected by immunohistochemical staining with anti-HDAC4 antibody in stage Ⅲ primary CRC tissues. Statistical significance between groups was evaluated using log rank test with * p < 0.05 as the threshold for significance.
Figure 5 HDAC4 depletion promotes cytoplasmic shift and degradation of Sox2 via increased lysine acetylation. (A) SW620 cells were treated with different concentrations of the deacetylase inhibitor trichostatin A (TSA; 10, 20, or 30 nM) for 48 h. The expression of HDAC4, HDAC1, Sox2, and Vinculin was examined by Western blot and qPCR. Data represent three independent experiments. Bar graphs show means ± SEM. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, ** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7. (B) SW620 cells were treated with 5 nM TSA for 24 h, followed by immunofluorescence staining with anti-Sox2 (green). Scale bar, 10 μm. (C) Immunofluorescence staining was performed using anti-Sox2 (green) and HDAC4 (red) antibodies to visualize their localization in SW480 and SW620 cells. Scale bar, 10 μm. (D) SW480 and SW620 cells were transfected with control or HDAC4 siRNA (20 nM) for 48 h. Cell lysates were analyzed by Western blot using anti-HDAC4, Sox2, and GAPDH antibodies. Full-length blots/gels are presented in Supplementary Figure S7. (E) SW620 cells were transfected with HDAC4 siRNA (20 nM) for 48 h, and the expression of Sox2 (green) was analyzed by immunofluorescence. Scale bar, 10 μm. (F) SW620 cells were transfected with control, HDAC1 or HDAC4 siRNAs (20 nM) for 48 h, with additional MG132 (25 nM) treatment for 24 h. Then, lysates were immunoprecipitated with lysine acetylation antibody, followed by Western blot analysis using anti-Sox2 antibody. Full-length blots/gels are presented in Supplementary Figure S7. (G) After fractionation into nuclear (NE) and cytosol (CE) fractions, SW620 cells were subjected to immunoprecipitation using Sox2 antibody. Western blot was performed with anti-HDAC4 and Sox2 antibodies. HDAC1 and GAPDH were used as loading controls for nuclear and cytosolic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (H) SW480 cells were co-transfected with plasmids encoding Flag-HDAC4 and Myc-Sox2 wild-type, K75Q mutant, or K75R mutant to investigate the interaction between Sox2 and HDAC4. After 48 h, cell lysates were immunoprecipitated with anti-Myc antibody, followed by immunoblot analysis using the indicated antibodies. Full-length blots/gels are presented in Supplementary Figure S7. (I) Kaplan–Meier curves for disease-free survival analysis were generated based on HDAC4-negative (n:135) and -positive (n:30) expression detected by immunohistochemical staining with anti-HDAC4 antibody in stage Ⅲ primary CRC tissues. Statistical significance between groups was evaluated using log rank test with * p < 0.05 as the threshold for significance.CC BY · PubMed Central
Figure 6 Decreased expression of Sox2 due to miR29a-induced HDAC4 suppression. (A) The expression of miR29a in colorectal cancer cell lines was measured by qPCR. Data represent the result of two independent experiments. (B) Immunofluorescence study was conducted to observe the localization and expression of Sox2 (green) after transfection of SW620 cells with an miR29a mimic for 72 h. Scale bar, 10 μm. (C,D) SW620 cells were transfected with scrambled control siRNA or an miR29a mimic for 72 h. The mRNA and protein expression of HDAC4 and Sox2 were quantified by qPCR and Western blot, respectively. Data represent the mean ± SEM of three independent experiments. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, ** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7.
Figure 6 Decreased expression of Sox2 due to miR29a-induced HDAC4 suppression. (A) The expression of miR29a in colorectal cancer cell lines was measured by qPCR. Data represent the result of two independent experiments. (B) Immunofluorescence study was conducted to observe the localization and expression of Sox2 (green) after transfection of SW620 cells with an miR29a mimic for 72 h. Scale bar, 10 μm. (C,D) SW620 cells were transfected with scrambled control siRNA or an miR29a mimic for 72 h. The mRNA and protein expression of HDAC4 and Sox2 were quantified by qPCR and Western blot, respectively. Data represent the mean ± SEM of three independent experiments. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, ** p < 0.005). Full-length blots/gels are presented in Supplementary Figure S7.CC BY · PubMed Central
Figure 7 Effects of O-GlcNAcylation by OGT and OGA on Sox2 expression and the combined effects of O-GlcNAcylation and acetylation. (A) The O-GlcNAcylation of Sox2 S246 residue in SW480 and SW620 cells was verified by manual inspection of LC-MS/MS spectra. The difference in O-GlcNAcylation of S246 within the O-glycopeptide SEASSSPPVVTSSSHSR sequence with EThcD spectra was confirmed in SW620 cells. Details of the mass spectrometric analysis and database search can be found in the Materials and Methods section. (B) Protein lysates of SW480 and SW620 cells were measured by Western blot using anti-O-GlcNAc-specific antibody and Sox2 antibody with α-tubulin as a loading control. Full-length blots/gels are presented in Supplementary Figure S7. (C) qPCR measurement of OGT and OGA mRNA levels in SW480 and SW620 cells. Data represent the mean ± SEM of three independent experiments. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, *** p < 0.001). (D) After transfection with Flag-OGT for 48 h, Western blot was performed using anti-Sox2 antibody. HDAC1 and α-tubulin were used as loading controls for nuclear and cytoplasmic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (E) Immunofluorescence study using anti-Sox2 (green) antibody after transfection with Flag-OGT for 48 h in SW480 cells. Scale bar, 10 μm. (F) After transfection with Flag-OGA for 48 h, Western blot was performed using anti-Sox2 antibody. HDAC1 and α-tubulin were used as loading controls for nuclear and cytoplasmic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (G) After transfection with OGT siRNA for 48 h and fractionation of nuclear and cytoplasmic fractions, Western blot analysis was conducted using anti-Sox2 antibody in SW620 cells. Lamin A/C and α-tubulin were used as loading and fractionation controls for nuclear and cytoplasmic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (H) Immunofluorescence study using anti-Sox2 antibody (green) after 48 h of treatment with OGT siRNA (20 nM) in SW620 cells, followed by 24 h of treatment with MG132 (25 nM). Scale bar, 10 μm. (I) SW480 cells were transfected with Myc-Sox2 wild-type or K75Q (acetylation mimic), S246A (O-GlcNAc prevention), or S246A/K75Q dual mutant vectors. Immunofluorescence study was performed with anti-Myc (green) antibody. Scale bar, 10 μm.
Figure 7 Effects of O-GlcNAcylation by OGT and OGA on Sox2 expression and the combined effects of O-GlcNAcylation and acetylation. (A) The O-GlcNAcylation of Sox2 S246 residue in SW480 and SW620 cells was verified by manual inspection of LC-MS/MS spectra. The difference in O-GlcNAcylation of S246 within the O-glycopeptide SEASSSPPVVTSSSHSR sequence with EThcD spectra was confirmed in SW620 cells. Details of the mass spectrometric analysis and database search can be found in the Materials and Methods section. (B) Protein lysates of SW480 and SW620 cells were measured by Western blot using anti-O-GlcNAc-specific antibody and Sox2 antibody with α-tubulin as a loading control. Full-length blots/gels are presented in Supplementary Figure S7. (C) qPCR measurement of OGT and OGA mRNA levels in SW480 and SW620 cells. Data represent the mean ± SEM of three independent experiments. Statistical significance was determined using unpaired Student’s t-tests (* p < 0.05, *** p < 0.001). (D) After transfection with Flag-OGT for 48 h, Western blot was performed using anti-Sox2 antibody. HDAC1 and α-tubulin were used as loading controls for nuclear and cytoplasmic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (E) Immunofluorescence study using anti-Sox2 (green) antibody after transfection with Flag-OGT for 48 h in SW480 cells. Scale bar, 10 μm. (F) After transfection with Flag-OGA for 48 h, Western blot was performed using anti-Sox2 antibody. HDAC1 and α-tubulin were used as loading controls for nuclear and cytoplasmic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (G) After transfection with OGT siRNA for 48 h and fractionation of nuclear and cytoplasmic fractions, Western blot analysis was conducted using anti-Sox2 antibody in SW620 cells. Lamin A/C and α-tubulin were used as loading and fractionation controls for nuclear and cytoplasmic fractions, respectively. Full-length blots/gels are presented in Supplementary Figure S7. (H) Immunofluorescence study using anti-Sox2 antibody (green) after 48 h of treatment with OGT siRNA (20 nM) in SW620 cells, followed by 24 h of treatment with MG132 (25 nM). Scale bar, 10 μm. (I) SW480 cells were transfected with Myc-Sox2 wild-type or K75Q (acetylation mimic), S246A (O-GlcNAc prevention), or S246A/K75Q dual mutant vectors. Immunofluorescence study was performed with anti-Myc (green) antibody. Scale bar, 10 μm.CC BY · PubMed Central
Figure 8 Post-translation modification of Sox2 for its regulation.
Figure 8 Post-translation modification of Sox2 for its regulation.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 53 references

Research works printed but not linked: 1

  1. Novak, D., Hüser, L., Elton, J.J., Umansky, V., Altevogt, P., and Utikal, J. (2020). Seminars in Cancer Biology, Academic Press.

Cited by

See all 5

Metadata

Authors
Seo, Y., Kim, D. K., Park, J., Park, S. J., Park, J. J., Cheon, J. H., & Kim, T. I.
Affiliations
Yonsei University (KR)
Corresponding author
Kim, Tae Il
Venue
Cancers
Publisher
MDPI AG
Published
2024-03-03
Volume
16
Issue
5
Pages
1035
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4392376423
Cited by
5
References
53
Citations by year
2026: 2 · 2025: 2 · 2024: 1
FWCI
0.68
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Research Foundation of Korea (NRF) (2021R1A2C2011641)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords
SOX2, colorectal cancer, post-translational modification, acetylation, O-GlcNAcylation, nuclear export signal, nucleocytoplasmic shuttling, proteasomal degradation, protein stability, HDAC4, P300, CBP/p300, miR-29a, pluripotency transcription factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer. https://app.cochat.ai/papers/10.3390/cancers16051035
The paper
Seo, Y., Kim, D. K., Park, J., Park, S. J., Park, J. J., Cheon, J. H., & Kim, T. I. (2024). A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer. Cancers. https://doi.org/10.3390/cancers16051035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.